Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges

Type 1 diabetes mellitus (T1D) is a chronic disease characterized by an autoimmune destruction of insulin-producing β-pancreatic cells. Although many advances have been achieved in T1D treatment, current therapy strategies are often unable to maintain perfect control of glycemic levels. Several stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Isaura Beatriz Borges, Kimura, Camila Harumi, Colantoni, Vitor Prado, Sogayar, Mari Cleide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284809/
https://www.ncbi.nlm.nih.gov/pubmed/35840987
http://dx.doi.org/10.1186/s13287-022-02977-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284809/
https://www.ncbi.nlm.nih.gov/pubmed/35840987
http://dx.doi.org/10.1186/s13287-022-02977-y

Ejemplares similares